Found: 19
Select item for more details and to access through your institution.
Persistence to 5-year hormonal breast cancer therapy: a French national population-based study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Risk of cancer with immunosuppressants compared to immunomodulators in multiple sclerosis: A nested case–control study within the French nationwide claims database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1421, doi. 10.1002/pds.5669
- By:
- Publication type:
- Article
Treatment resistant depression incidence and prevalence using the French nationwide claims database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 169, doi. 10.1002/pds.5082
- By:
- Publication type:
- Article
Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 2, p. 194, doi. 10.1002/pds.4690
- By:
- Publication type:
- Article
National trends in use and costs of oral anticancer drugs in France: An 8-year population-based study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 10, p. 1233, doi. 10.1002/pds.4282
- By:
- Publication type:
- Article
Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality.
- Published in:
- Journal of Bone & Mineral Research, 2023, v. 38, n. 8, p. 1064, doi. 10.1002/jbmr.4821
- By:
- Publication type:
- Article
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
- Published in:
- BMC Medical Research Methodology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12874-021-01285-y
- By:
- Publication type:
- Article
Pharmacological treatment patterns in heart failure: a population-based cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 1, p. 97, doi. 10.1007/s00228-019-02758-2
- By:
- Publication type:
- Article
NSAIDs and COVID-19: A Systematic Review and Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Does Ibuprofen Worsen COVID-19?
- Published in:
- 2020
- By:
- Publication type:
- editorial
Treatment Modalities and Survival in Older Adults with Metastatic Colorectal Cancer in Real Life.
- Published in:
- Journal of the American Geriatrics Society, 2019, v. 67, n. 5, p. 913, doi. 10.1111/jgs.15858
- By:
- Publication type:
- Article
Real‐World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study.
- Published in:
- JBMR Plus, 2023, v. 7, n. 9, p. 1, doi. 10.1002/jbm4.10789
- By:
- Publication type:
- Article
Drug utilization analysis of osteoporosis medications in seven European electronic health databases.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 10, p. 1771, doi. 10.1007/s00198-023-06837-0
- By:
- Publication type:
- Article
Comparative effectiveness of dimethyl fumarate in multiple sclerosis.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 3, p. 1268, doi. 10.1111/bcp.15071
- By:
- Publication type:
- Article
Adverse events reported for Mirena levonorgestrel‐releasing intrauterine device in France and impact of media coverage.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 9, p. 2126, doi. 10.1111/bcp.14027
- By:
- Publication type:
- Article
Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID‐19 Pandemic.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 8, p. 1173, doi. 10.1002/acr.25331
- By:
- Publication type:
- Article
Incidence and risk of cancer among multiple sclerosis patients: A matched population‐based cohort study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 4, p. 1091, doi. 10.1111/ene.15226
- By:
- Publication type:
- Article
PRognostic factor of Early Death In phase II Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model).
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2819-7
- By:
- Publication type:
- Article